Keyphrases
Cannabidiol
100%
Morphine
54%
Cannabinoids
42%
BV2 Microglia
38%
Morphine Tolerance
29%
Non-psychoactive Cannabinoids
27%
Antinociceptive
26%
Memantine
26%
N-methyl-D-aspartate Receptor Antagonist
25%
Δ9-tetrahydrocannabinol (Δ9-THC)
22%
Lipopolysaccharide
21%
Encephalitogenic T Cells
19%
Microglial Activation
19%
Antidepressants
18%
Microglial Cells
18%
N-methyl-D-aspartate Receptor (NMDAR)
16%
Microglia
15%
Morphine Antinociception
14%
Tail-flick Test
13%
Available N
12%
Analgesic Effect
12%
Immune Cell Membranes
12%
Extracellular Vesicles
12%
Multiple Sclerosis
11%
Anti-inflammatory Effect
10%
Neuroscience
Cannabidiol
94%
Cannabinoid
71%
Microglia
65%
Morphine
37%
T Cell
31%
Anti-Inflammatory
29%
Tetrahydrocannabinol
23%
Lipopolysaccharide
23%
Antidepressant
18%
Memantine
14%
NMDA Receptor Antagonist
12%
Glutamate Carboxypeptidase II
12%
Receptor Antagonist
12%
Multiple Sclerosis
11%
Receptor
11%
Messenger RNA
10%
Pharmacology, Toxicology and Pharmaceutical Science
Cannabidiol
60%
Morphine
49%
Cannabinoid
41%
Memantine
23%
NMDA Receptor Antagonist
21%
Receptor
12%
Analgesic Agent
12%
Glutamic Acid
12%
Glutamate Carboxypeptidase II Inhibitor
12%
Aspartic Acid
10%
Multiple Sclerosis
10%
Morphine-Induced Antinociception
10%